4.2 Article

A new multiplex PCR strategy for the simultaneous determination of four genetic polymorphisms affecting HIV-1 disease progression

Journal

JOURNAL OF IMMUNOLOGICAL METHODS
Volume 252, Issue 1-2, Pages 147-151

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/S0022-1759(01)00349-0

Keywords

chemokine receptors; HIV; CCR5 Delta 32; CCR2 64I; SDF1 3 ' A; CCR5 promoter 59029 A/G transition

Ask authors/readers for more resources

The CCR5 Delta 32, CCR2 64I, SDF1 3'A, and CCR5 promoter 59029 polymorphisms have been suggested to influence HIV-I disease progression. Furthermore, the CCR5 Delta 32 and the CCR2 64I polymorphisms have been associated with various other diseases, The purpose of the present study was to develop a multiplex assay for the simultaneous determination of these four polymorphisms. Results obtained with the multiplex assay were compared to results obtained by conventional RFLP-PCR and no differences were observed. The multiples assay offers a quick tool for the determination of the CCR5 Delta 32, CCR2 64I, SDF1 3'A, and CCR5 promoter 59029 A/G polymorphisms. (C) 2001 Elsevier Science B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available